A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy
- 29 July 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (5) , 305-311
- https://doi.org/10.1056/nejm199907293410501
Abstract
Among patients with fever and neutropenia during cancer chemotherapy who have a low risk of complications, oral administration of empirical broad-spectrum antibiotics may be an acceptable alternative to intravenous treatment.Keywords
This publication has 18 references indexed in Scilit:
- Outpatient treatment of febrile neutropenic patients with cancerEuropean Journal Of Cancer, 1995
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancerCancer, 1993
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patientsThe Lancet, 1992
- Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.Journal of Clinical Oncology, 1992
- The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentationArchives of internal medicine (1960), 1988
- Controversies in the Management of Febrile Neutropenic Cancer PatientsCancer Investigation, 1988
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Fever in the Pediatric and Young Adult Patient with CancerMedicine, 1982
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966